- Home
- EPSM vs OLMA Comparison
EPSM vs OLMA Comparison
Compare EPSM & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSM
- OLMA
- Stock Information
- Founded
- EPSM 2010
- OLMA 2006
- Country
- EPSM China
- OLMA United States
- Employees
- EPSM N/A
- OLMA N/A
- Industry
- EPSM
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- EPSM
- OLMA Health Care
- Exchange
- EPSM Nasdaq
- OLMA Nasdaq
- Market Cap
- EPSM 467.5M
- OLMA 560.7M
- IPO Year
- EPSM 2025
- OLMA 2020
- Fundamental
- Price
- EPSM $30.28
- OLMA $10.48
- Analyst Decision
- EPSM
- OLMA Strong Buy
- Analyst Count
- EPSM 0
- OLMA 5
- Target Price
- EPSM N/A
- OLMA $24.00
- AVG Volume (30 Days)
- EPSM 1.1M
- OLMA 1.2M
- Earning Date
- EPSM 11-24-2025
- OLMA 11-11-2025
- Dividend Yield
- EPSM N/A
- OLMA N/A
- EPS Growth
- EPSM N/A
- OLMA N/A
- EPS
- EPSM 0.02
- OLMA N/A
- Revenue
- EPSM $12,518,070.00
- OLMA N/A
- Revenue This Year
- EPSM N/A
- OLMA N/A
- Revenue Next Year
- EPSM N/A
- OLMA N/A
- P/E Ratio
- EPSM $1,505.84
- OLMA N/A
- Revenue Growth
- EPSM N/A
- OLMA N/A
- 52 Week Low
- EPSM $4.23
- OLMA $2.86
- 52 Week High
- EPSM $155.00
- OLMA $13.51
- Technical
- Relative Strength Index (RSI)
- EPSM N/A
- OLMA 70.04
- Support Level
- EPSM N/A
- OLMA $8.01
- Resistance Level
- EPSM N/A
- OLMA $11.54
- Average True Range (ATR)
- EPSM 0.00
- OLMA 0.79
- MACD
- EPSM 0.00
- OLMA 0.14
- Stochastic Oscillator
- EPSM 0.00
- OLMA 72.61
About EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.